ArticleBMC primary care2026
Prevalence and associated factors of probable neuropathic pain among adults with type 2 diabetes in Turkish primary care: a cross-sectional study.
Article in BMC primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeuropathic pain is a common and disabling complication of type 2 diabetes mellitus (T2DM) that adversely affects quality of life and functional capacity, yet it is frequently under-recognised and undertreated, particularly in primary care. Most evidence on diabetic neuropathic pain comes from hospital-based populations, and data from Turkish primary care-especially among working-age adults-are limited. We aimed to estimate the prevalence of probable neuropathic pain among adults with T2DM in primary care and to identify associated demographic, clinical and laboratory factors.
methodsCross-sectional study of adults aged 18-65 years with T2DM duration ≥ 1 year registered at a family health centre in Türkiye. A stratified random sample of 400 patients was invited. Data were collected by interview and medical record review. Probable neuropathic pain was defined as the Self-completed Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) score ≥ 12. Associations were examined using multivariable logistic regression.
resultsOut of 400 patients invited, 301 (75.3%) participated in the study. Participants were 53.2% female; mean age 55.1 ± 9.7 years; median diabetes duration 120 months (interquartile range (IQR) 48-180). The prevalence of probable neuropathic pain was 25.9% (95% confidence interval (CI) 21.1-31.3). In the multivariable model, glycated haemoglobin (HbA1c) ≥ 9% (vs. < 7%; odds ratio (OR) 2.29, 95% CI 1.11-4.75) and primary school or less education (vs. university or higher; OR 3.04, 95% CI 1.01-9.13) were independently associated with probable neuropathic pain, whereas age, diabetes duration, hypertension and comorbidity were not independently significant after adjustment.
conclusionsAbout one in four working-age adults with T2DM in primary care reported probable neuropathic pain. Screening and education-tailored counselling, alongside intensified support for glycaemic control, may be particularly important for patients with poor glycaemic control and lower education.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.